Real-world, retrospective study evaluating thromboembolic events, associated risk factors, and health-care resource utilization in Japanese patients with polycythemia vera
Author:
Funder
Novartis Pharma KK
Publisher
Springer Science and Business Media LLC
Subject
Hematology
Link
https://link.springer.com/content/pdf/10.1007/s12185-020-02887-w.pdf
Reference36 articles.
1. Hensley B, Geyer H, Mesa R. Polycythemia vera: current pharmacotherapy and future directions. Expert Opin Pharmacother. 2013;14:609–17.
2. Spivak JL. Polycythemia vera: myths, mechanisms, and management. Blood. 2002;100:4272–90.
3. Finazzi G, Barbui T. Evidence and expertise in the management of polycythemia vera and essential thrombocythemia. Leukemia. 2008;22:1494–502.
4. Griesshammer M, Gisslinger H, Mesa R. Current and future treatment options for polycythemia vera. Ann Hematol. 2015;94:901–10.
5. Stein BL, Oh ST, Berenzon D, Hobbs SG, Kremyanskaya M, Rampal RK, et al. Polycythemia vera: an appraisal of the biology and management 10 years after the discovery of JAK2 V617F. J Clin Oncol. 2015;33:3953–60.
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Clinical management of iron deficiency anemia in Japan: iron prescription patterns, treatment effectiveness, and assessments;International Journal of Hematology;2024-05-28
2. Patient characteristics, treatment patterns, healthcare resource utilization, and costs among patients diagnosed with neurofibromatosis type 1 with and without plexiform neurofibromas in Japan;Current Medical Research and Opinion;2024-03-07
3. Diagnosis and Management of Cardiovascular Risk in Patients with Polycythemia Vera;Vascular Health and Risk Management;2023-11
4. Healthcare resource utilization in patients with myeloproliferative neoplasms: A Danish nationwide matched cohort study;European Journal of Haematology;2022-08-26
5. Clinical characteristics of Japanese patients with polycythemia vera: results of the JSH-MPN-R18 study;International Journal of Hematology;2022-07-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3